Immuno-Biological Laboratories Co Ltd
TSE:4570
Cash Flow Statement
Cash Flow Statement
Immuno-Biological Laboratories Co Ltd
Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Sep-2011 | Mar-2012 | Sep-2012 | Mar-2013 | Sep-2013 | Mar-2014 | Sep-2014 | Mar-2015 | Sep-2015 | Mar-2016 | Sep-2016 | Mar-2017 | Sep-2017 | Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||||||||||||||||||
Net Income |
(36)
|
18
|
42
|
110
|
38
|
(9)
|
81
|
134
|
(37)
|
46
|
171
|
163
|
(43)
|
(112)
|
(59)
|
(161)
|
(114)
|
(30)
|
(101)
|
(2 089)
|
(2 019)
|
(52)
|
(55)
|
(164)
|
(371)
|
(659)
|
(639)
|
(311)
|
(278)
|
(250)
|
(187)
|
(281)
|
(119)
|
|
Depreciation & Amortization |
(4)
|
(15)
|
(4)
|
(11)
|
1
|
31
|
4
|
34
|
109
|
102
|
95
|
86
|
88
|
101
|
108
|
0
|
103
|
84
|
108
|
340
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Non-Cash Items |
15
|
3
|
(4)
|
(8)
|
(3)
|
5
|
28
|
27
|
33
|
10
|
5
|
(83)
|
(68)
|
21
|
(7)
|
40
|
(60)
|
(76)
|
42
|
1 722
|
1 712
|
7
|
12
|
7
|
39
|
78
|
93
|
87
|
97
|
134
|
160
|
349
|
252
|
|
Cash Taxes Paid |
(44)
|
(106)
|
1
|
32
|
(0)
|
(0)
|
0
|
0
|
4
|
4
|
3
|
3
|
11
|
16
|
7
|
4
|
4
|
2
|
5
|
5
|
3
|
3
|
4
|
4
|
5
|
7
|
5
|
3
|
8
|
8
|
9
|
8
|
9
|
|
Cash Interest Paid |
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
1
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Change in Working Capital |
278
|
372
|
(235)
|
(313)
|
19
|
19
|
36
|
71
|
39
|
(32)
|
35
|
63
|
23
|
3
|
(16)
|
(95)
|
(46)
|
4
|
(135)
|
(29)
|
117
|
119
|
(30)
|
(87)
|
17
|
(28)
|
(29)
|
30
|
16
|
22
|
(18)
|
11
|
4
|
|
Cash from Operating Activities |
253
N/A
|
378
+50%
|
(201)
N/A
|
(223)
-11%
|
55
N/A
|
46
-16%
|
148
+222%
|
265
+79%
|
144
-46%
|
126
-13%
|
306
+143%
|
229
-25%
|
0
N/A
|
12
N/A
|
27
+122%
|
(101)
N/A
|
(116)
-15%
|
(17)
+85%
|
(86)
-406%
|
(56)
+35%
|
85
N/A
|
74
-13%
|
(73)
N/A
|
(244)
-234%
|
(315)
-29%
|
(609)
-93%
|
(574)
+6%
|
(194)
+66%
|
(165)
+15%
|
(93)
+43%
|
(44)
+52%
|
80
N/A
|
137
+72%
|
|
Investing Cash Flow | ||||||||||||||||||||||||||||||||||
Capital Expenditures |
(25)
|
(51)
|
31
|
40
|
5
|
3
|
35
|
9
|
(47)
|
(28)
|
(17)
|
(28)
|
(70)
|
(61)
|
(47)
|
0
|
(100)
|
(698)
|
(1 025)
|
(402)
|
(13)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
0
|
0
|
|
Other Items |
646
|
264
|
65
|
123
|
43
|
43
|
75
|
60
|
76
|
24
|
9
|
(7)
|
(42)
|
(76)
|
(198)
|
93
|
377
|
90
|
(168)
|
(57)
|
57
|
(5)
|
(6)
|
(593)
|
(593)
|
11
|
11
|
(4)
|
(34)
|
(156)
|
(181)
|
30
|
85
|
|
Cash from Investing Activities |
620
N/A
|
213
-66%
|
96
-55%
|
163
+70%
|
48
-70%
|
46
-5%
|
110
+141%
|
69
-37%
|
29
-58%
|
(4)
N/A
|
(8)
-121%
|
(34)
-310%
|
(112)
-225%
|
(137)
-22%
|
(246)
-79%
|
22
N/A
|
276
+1 165%
|
(608)
N/A
|
(1 194)
-96%
|
(458)
+62%
|
44
N/A
|
(6)
N/A
|
(6)
0%
|
(593)
-9 317%
|
(593)
+0%
|
11
N/A
|
11
+2%
|
(17)
N/A
|
(47)
-174%
|
(156)
-229%
|
(181)
-16%
|
30
N/A
|
85
+184%
|
|
Financing Cash Flow | ||||||||||||||||||||||||||||||||||
Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
103
|
538
|
0
|
0
|
0
|
198
|
744
|
575
|
0
|
0
|
0
|
0
|
0
|
468
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
73
|
75
|
66
|
(33)
|
(33)
|
(33)
|
186
|
176
|
(49)
|
182
|
166
|
(93)
|
94
|
412
|
1 573
|
1 235
|
(136)
|
(114)
|
(124)
|
(139)
|
(109)
|
(66)
|
(16)
|
139
|
144
|
15
|
1
|
1
|
|
Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(30)
|
(30)
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other |
(0)
|
(1)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
(1)
|
0
|
(1)
|
0
|
7
|
6
|
(0)
|
(2)
|
(10)
|
(5)
|
2
|
(2)
|
(3)
|
(2)
|
(4)
|
(2)
|
(1)
|
(278)
|
0
|
(200)
|
0
|
0
|
(0)
|
(0)
|
0
|
|
Cash from Financing Activities |
(3)
N/A
|
(5)
-112%
|
(0)
+98%
|
(0)
N/A
|
0
N/A
|
73
N/A
|
75
+3%
|
67
-11%
|
(33)
N/A
|
(33)
N/A
|
(33)
N/A
|
186
N/A
|
256
+38%
|
465
+82%
|
616
+33%
|
164
-73%
|
(102)
N/A
|
287
N/A
|
1 159
+304%
|
2 146
+85%
|
1 261
-41%
|
(138)
N/A
|
(118)
+15%
|
(126)
-7%
|
(141)
-11%
|
81
N/A
|
125
+54%
|
(216)
N/A
|
(61)
+72%
|
144
N/A
|
15
-90%
|
1
-93%
|
1
+0%
|
|
Change in Cash | ||||||||||||||||||||||||||||||||||
Effect of Foreign Exchange Rates |
0
|
(4)
|
0
|
4
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
1
|
(1)
|
2
|
5
|
2
|
6
|
12
|
8
|
(2)
|
(5)
|
(1)
|
2
|
(0)
|
3
|
4
|
(1)
|
(1)
|
(3)
|
5
|
9
|
2
|
4
|
2
|
2
|
|
Net Change in Cash |
871
N/A
|
582
-33%
|
(105)
N/A
|
(55)
+47%
|
103
N/A
|
164
+60%
|
333
+103%
|
401
+20%
|
140
-65%
|
90
-35%
|
264
+193%
|
382
+44%
|
149
-61%
|
342
+130%
|
403
+18%
|
96
-76%
|
66
-32%
|
(340)
N/A
|
(127)
+63%
|
1 630
N/A
|
1 392
-15%
|
(71)
N/A
|
(194)
-172%
|
(959)
-395%
|
(1 050)
-9%
|
(517)
+51%
|
(440)
+15%
|
(422)
+4%
|
(264)
+38%
|
(103)
+61%
|
(206)
-100%
|
113
N/A
|
225
+100%
|
|
Free Cash Flow | ||||||||||||||||||||||||||||||||||
Free Cash Flow |
228
N/A
|
328
+44%
|
(170)
N/A
|
(183)
-7%
|
60
N/A
|
49
-19%
|
184
+276%
|
274
+49%
|
98
-64%
|
98
+0%
|
289
+195%
|
201
-30%
|
(70)
N/A
|
(49)
+31%
|
(20)
+58%
|
(101)
-402%
|
(216)
-113%
|
(715)
-230%
|
(1 111)
-56%
|
(458)
+59%
|
72
N/A
|
73
+1%
|
(73)
N/A
|
(244)
-234%
|
(315)
-29%
|
(609)
-93%
|
(574)
+6%
|
(208)
+64%
|
(165)
+21%
|
(93)
+43%
|
(44)
+52%
|
80
N/A
|
137
+72%
|